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Abstract
Purpose Curcumin exerts its anti-inflammatory activity via
inhibition of nuclear factor κB. Oropharyngeal epithelia
and residing bacteria closely interact in inflammation and
infection. This in vitro model investigated the effects of
curcumin on bacterial survival, adherence to, and invasion
of upper respiratory tract epithelia, and studied its anti-
inflammatory effect. We aimed to establish a model, which
could offer insights into the host–pathogen interaction in
cancer therapy induced mucositis.
Methods Moraxella catarrhalis (Mcat) and the oropharyngeal
epithelial cell line Detroit 562 were used. Time–kill curves
assessed the inhibition of bacterial growth and adherence
assays and gentamicin protection assays determined the effect
of curcumin-preincubated cells on bacterial adherence and
invasion. Curcumin-mediated inhibition of pro-inflammatory
activation by Mcat was determined via interleukin-8 concen-
trations in the supernatants. The synergistic role of secretory
IgA (sIgA) on adherence was investigated.
Results Curcuminwas bactericidal at concentrations >50 µM.
Preincubation of Detroit cells for 60 min demonstrated that
concentrations >100 µM inhibited bacterial adherence.
Together with sIgA, curcumin inhibited adherence at concen-
trations ≥50 µM. Both 100 and 200 µM curcumin signifi-
cantly inhibited Mcat cell invasion. Finally, curcumin
inhibited Mcat-induced pro-inflammatory activation by
strongly suppressing IL-8 release. At a concentration of
200 µM, 10 min of curcumin exposure inhibited IL-8 release
significantly, and complete suppression required a pre-
exposure time of ≥45 min.
Conclusion Curcumin, in clinically relevant concentrations
for topical use, displayed strong antibacterial effect against
a facultative upper respiratory tract pathogen by inhibiting
bacterial growth, adherence, invasion, and pro-
inflammatory activation of upper respiratory tract epithelial
cells in vitro.
Keywords Curcumin . Bacterial adherence .
Bacterial invasion . Interleukin-8 . Otitis media . Mucositis
Introduction
Upper respiratory tract mucosae are physiologically colo-
nized by numerous microorganisms, with which they live in
mutual, non-inflammatory coexistence. Cancer therapy-
induced mucosal surface injury deranges this delicate
balance and leads to inflammation, local tissue damage,
and ultimately, microbial invasion. In this study, we tested
topical curcumin for its capacity to inhibit bacteria-induced
deleterious effects on human upper respiratory tract
epithelial cells in vitro. As curcumin (diferuloylmethane),
the yellow pigment of the curry spice and major component
of turmeric (Curcuma longa Linn.), has been used in
traditional medicine for centuries, its anti-inflammatory
properties have evoked major scientific interest in the
recent past as light was shed on its molecular actions, e.g.,
as a potent inhibitor of nuclear factor κB (NF-κB). We used
Moraxella catarrhalis (Mcat), a Gram-negative aerobic
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bacterium, which is a major, exclusively human, facultative
pathogen occupying the oro- and nasopharyneal niche.
Mcat accounts for common infections throughout the entire
life: acute otitis media and sinusitis in childhood [21, 26],
as well as bronchitis and exacerbations of chronic obstruc-
tive pulmonary diseases (COPD) in the elderly [20].
Cumulative nasopharyngeal colonization rates with Mcat
reach up to 80% in early childhood [9], and Mcat carriage
may even be underestimated due to its ability to invade
respiratory cells and submucosal tissue and thus escape
detection by respiratory surface swabbing [13, 30].
As human respiratory tract epithelia form a large surface,
they are constantly in contact with a variety of (facultative)
pathogens. Intact mucosal surfaces and defense mecha-
nisms essentially contribute to pathogen control and
facilitate non-inflammatory coexistence. Rapid growth,
adherence to, and penetration of epithelial cells, on the
other hand, may herald the initiation of bacterial infection
[22, 24] as bacteria are capable of triggering inflammatory
cell responses in respiratory epithelia via, e.g., NF-κB
activation and subsequent interleukin-8 (IL-8) release [28,
29, 33]. IL-8 plays a critical role in neutrophil chemotaxis
toward sites of infection as well as recruitment to chronic
inflammatory sites in COPD patients [15].Not only in
infection but also in the onset of mucosal barrier injury,
which precedes oral mucositis, the NF-κB pathway of
cytokine release plays a critical role. Thus, the large patient
group receiving anti-cancer treatment comes into consider-
ation: cytotoxic chemotherapy and irradiation cause DNA
damage, which itself can activate NF-κB [6, 31] and the
subsequent release of pro-inflammatory cytokines, adhesion
molecules, and cyclooxygenase-2 [7, 18]. Damaged muco-
sal barriers cannot protect against the resident flora, and
(systemic) infection may ensue. For instance, the risk of
infection in chemotherapy-induced neutropenia was shown
to be more than doubled in patients with mucositis, with the
risk of infection being proportional to the severity of
mucositis [8].
Inhibition of NF-κB thus could offer a tool to reduce
bacteria-induced pro-inflammatory epithelial cell responses
and, at the same time, provide local protection against NF-
κB mediated mucosal barrier injury in the early stages [18]
of mucositis in anti-cancer treatment. The curcumin
modulates various cell signaling pathways and is a potent
inhibitor of cytoplasmic NF-κB activation and subsequent
cytokine release [16, 27, 35]. Inactive NF-κB is bound to
an inhibitory molecule, IκBα, and is restrained to the
cytoplasm. As a response to extracellular stimuli, IκB
kinase (IKK) complex phosphorylates IκBα. Phosphorylat-
ed IκBα is degraded and consecutively releases active NF-
κB, which can then translate to the nucleus, where it binds
to specific DNA sequences resulting in transcriptional
activation of several genes [4]. This signal cascade induces
inflammatory cell responses, which can be blocked by
curcumin [16, 35]. It has also been demonstrated that NF-
κB stimulates CEACAM-1 expression in epithelial cells
[19], a molecule used by Mcat and other pharyngeal
pathogens to adhere to and invade these cells.
We hypothesized that the inhibition of NF-κB by curcumin
may reduce the adherence of bacteria to human respiratory
tract epithelia. Thus, the current study addressed the effect of
curcumin on growth, adherence, and invasion of bacteria to
human upper respiratory tract cells in an in vitro model with
Mcat as a representative of the human pharyngeal flora.
Methods
Bacterial strains, cell lines, and culture conditions The
Mcat strain 25238 was purchased from the American Type
Culture Collection (ATCC). The laboratory strain O35E is a
middle ear isolate from a child with otitis media [14].
Bacteria were cultured on brain–heart infusion (BHI) agar
plates (Difco, Detroit, MI, USA) at 37°C in an 5% CO2
atmosphere or in BHI broth at 37°C and 200 rpm. In some
experiments, bacteria were heat-inactivated by re-
suspension of live bacteria in phosphate-buffered saline
(PBS) and incubation at 60°C for 60 min. The human
pharyngeal cell line Detroit 562 (ATCC CCL 138) was
maintained in Eagle's minimal essential medium (MEM;
Invitrogen, Basel, Switzerland) supplemented with 10% of
heat-inactivated fetal calf serum (FCS), 2 mM of L-
glutamine, 1 mM sodium pyruvate (Sigma, St. Louis,
MO, USA), 1× nonessential amino acids (Sigma),
100 U/ml penicillin, and 100 μg/ml streptomycin at 37°C
in 5% CO2.
Reagents Curcumin (diferuloylmethane) was purchased
from Sigma (no. C1386). For use in experimental proce-
dures, curcumin was solubilized in dimethyl sulfoxide
(DMSO) (stock solution, 73.678 mg/ml, i.e., 200 mM)
and added to cell culture medium.
Autoagglutination assay Bacteria were cultured overnight
on BHI plates, scraped from the plates, and re-suspended in
10 ml of PBS or PBS with 100 or 200 μM curcumin,
respectively, to reach an OD600 of 2.0. The suspensions
were left in glass tubes at room temperature or at 37°C. The
OD600 was measured from 1-ml aliquots taken from the top
of the suspensions after 0, 15, 30, 45, and 60 min.
Time–kill analysis of Mcat exposed to curcumin Bacteria
were grown in BHI broth to an OD600 of 0.4 (∼5×107 cfu/
ml), aliquoted, and subsequently grown in BHI supple-
mented with 0, 20, 50, or 100 μM curcumin, respectively.
Growth in DMSO was used as control. Quantitative
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cultures were obtained by serial plating of 100-μl aliquots
at 0, 60, 120, 180, and 240 min, respectively.
Expression of outer membrane proteins (OMP) by bacteria
exposed to curcumin OMP preparations of the strains
25238 and O35E exposed to 0 or 20 μM curcumin were
prepared by the EDTA buffer method [3], resolved by SDS-
PAGE (7.5% polyacrylamide), and electrotransferred to
polyvinylidene fluoride membranes (Immobilon-P, Milli-
pore Corporation, Bedford, MA, USA). Immunoblot anal-
ysis was performed using the monoclonal antibodies 24B5
(specific for UspA1) [2] and 10F3 (specific for CopB) [14],
diluted 1:4, as respective primary antibodies, and a 1:4,000
diluted goat anti-mouse IgG labeled with horseradish
peroxidase (Sigma). SuperSignal West Pico chemilumines-
cent substrate (Pierce Chemical Co., Rockford, IL, USA)
was used for detection of antibody binding.
Epithelial cell adherence assays The ability of Mcat to
adhere to human epithelial cells in vitro was measured as
previously described [1] with the following modifications.
Epithelial cells (∼2.5×105 per well) grown to a confluent
monolayer in 24-well tissue culture plates were exposed to
various concentrations of curcumin (0–200 μM) for 60 min
in MEM supplemented with 10% FCS followed by washing
three times in MEM. Bacteria were grown overnight and
adjusted to the appropriate multiplicities of infection (MOI).
In some experiments, bacteria were also incubated with
human colostrum secretory IgA (sIgA) (Sigma), incubated
for 20 min at 37°C, centrifuged at 150 rpm for 5 min, and
resuspended in MEM. Bacteria were added to tissue culture
wells in tissue culture medium without antibiotics, centri-
fuged for 5 min at 1500 rpm, and subsequently incubated for
30 min at 37°C. Wells were then washed five times in MEM
and trypsinized, and the suspensions were cultured quanti-
tatively to determine the number of adherent bacteria. Data
were expressed as the proportion of bacteria of the original
inoculum adhering to the epithelial cells. Each strain was
analyzed in triplicate, and at least three experiments were
performed. Cell viability was ascertained morphologically
and by trypan blue exclusion. Curcumin and/or bacteria-
induced apoptosis was ruled out by fixation and staining of
cells post-treatment with the cleaved caspase 3 antibody Asp
175 (Cell Signalling Technology, Inc., Danvers, MA, USA),
followed by secondary staining with goat-anti-rabbit Cy3
(Dianova GmbH, Hamburg, Germany) and examination
using fluorescent microscopy. To investigate whether pre-
incubation of cells with curcumin is essential to achieve an
inhibition of adherence, bacteria were re-suspended in MEM
containing 0, 25, or 50 μM curcumin with or without sIgA
(100 μg/ml) and were then directly used to infect cellular
monolayers and perform adherence assays as described
above.
Epithelial cell invasion assays Bacterial invasion was
estimated using a gentamicin protection assay as previously
described [32] with the following modifications. Cells were
prepared in medium without antibiotics and subsequently
exposed to curcumin as described for the adherence assays.
After washing, bacteria were added at the indicated MOI,
centrifuged for 5 min at 1500 rpm, and incubated for 3 h at
37°C in 5% CO2. To determine the number of intracellular
bacteria, the infected monolayer was washed three times in
PBS and treated with gentamicin sulfate (200 µg/ml) for 2 h
at 37°C. After washing, cells were detached from the plastic
surface by treatment with 0.25% trypsin-EDTA, lysed by
the addition of 1% saponin, and serially diluted in PBS for
quantitative bacterial culture. Invasion ratios were calculat-
ed by dividing the number of colony-forming units
recovered after gentamicin exposure by the number of
colony-forming units inoculated.
Determination of interleukin-8 (IL-8) secretion by Detroit
cells stimulated with Mcat Monolayers were prepared, pre-
incubated with curcumin at various concentrations, and infected
at the indicated MOI as described. For 4-h experiments, live
bacteria were used. For 16-h experiments, bacteria were heat-
inactivated. Negative controls consisted of medium without
bacteria. Ten microgram per milliliter of lipopolysaccharide
from Salmonella enteritidis (Sigma) was used as positive
control. Supernatants were collected, centrifuged, and stored at
−80°C. IL-8 was determined using a commercially available
ELISA kit according to the manufacturer’s protocol (R&D
Systems, Minneapolis, MN, USA). In an experiment designed
to investigate the effect of pre-incubation of bacteria with sIgA
on IL-8 release, heat-inactivated bacteria were pre-incubated
in MEM containing 10% FCS with or without sIgA
(100 μg/ml) for 20 min at 37°C, centrifuged at 150 rpm for
5 min, and resuspended in MEM before infection of
monolayers. IL-8 release was determined after 4 h as
described.
Statistics The GraphPad Prism® version 5.02 statistics
tools (GraphPad Software, La Jolla, CA, USA) were used
for analysis of variance (ANOVA) and Student’s t tests as
indicated.
Results
Curcumin inhibits growth of Mcat in vitro Four-hour time–
kill analyses of the strains 25238 and 035E, respectively
(Fig. 1a, b) demonstrated that concentrations of curcumin
>50 μM were bactericidal and that O35E was more
susceptible than 25238. Curcumin at concentrations up to
200 μM did not affect the capacity of Mcat to autoag-
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glutinate (data not shown). This was an important finding
with respect to the reproducibility of quantitative cultures.
Growth of both strains in a medium containing 20 μM
curcumin did not appear to affect the organism’s outer
membrane profile and its expression of the UspA1 adhesin
and the iron-regulated CopB protein (Fig. 1c).
Curcumin inhibits the adherence of Mcat to human
pharyngeal cells Adherence assays [1] were performed to
assess whether pre-incubation of Detroit cells with various
concentrations of curcumin for 60 min preceding the assay
had an effect on the adherence of Mcat to the cellular
surface. Concentrations ≤50 μM had no effect and are not
shown. However, at 100 and 200 μM, respectively,
adherence of both strain 25238 (Fig. 2a) and O35E
(Fig. 2b) was significantly reduced. In this setting,
curcumin was washed off from the monolayers before
infection with live bacteria. Thus, the quantitative bacterial
cultures used to determine the proportion of adherent
bacteria was not affected by the bactericidal effect of
curcumin.
Curcumin enhances the inhibitory effect of sIgA on
bacterial adherence In an experimental setup more closely
mimicking the pharyngeal surface environment and the
potential therapeutic use of curcumin, bacteria, sIgA
(100 μg/ml) and curcumin (50 μM in order to maintain
bacterial viability) were pre-incubated in tissue culture
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Fig. 1 Four-hour time–kill analysis of strains 25238 (a) and O35E
(b), respectively, exposed to various concentrations of curcumin
(diamond 0 μM; circle 20 μM; square 50 μM; triangle 100 μM).
Subpanel c (left) demonstrates Commassie blue-stained OMP profiles
of strains O35E and 25238 grown in BHI (lanes 1 and 3) or in BHI
supplemented with 20 μM curcumin (lanes 2 and 4). Immunoblots
with mAb 24B5 (035E, lane 5; 25238, lane 6) and mAb 10F3 (035E,
lane 7; 25238, lane 8) are shown on the right
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medium for 30 min. Subsequently, bacteria (strain 25238)
were centrifuged and resuspended at an MOI of 30, and a
standard adherence assay was performed. Figure 3 demon-
strates that sIgA significantly inhibited adherence when
combined with 50 μM curcumin, while both sIgA and
50 μM curcumin alone were less effective and did not
reduce adherence significantly. Thus, low-dose curcumin
added to the inhibitory effect of sIgA.
Curcumin inhibits invasion of Mcat into Detroit cells Mcat
is capable to invade epithelial cells [30, 32]. Here, we
demonstrate (Fig. 4) that pre-incubation of Detroit cells
with both 100 or 200 μM curcumin for 60 min resulted in a
significant inhibition of cellular invasion as determined
using a standard gentamicin protection assay [32].
Curcumin inhibits IL-8 secretion by Detroit cells Preliminary
data demonstrated that pre-incubation of Detroit cells with
≥ 100 μM curcumin for 60 min inhibited IL-8 secretion
induced by subsequent infection of cells with live strain
25238 for 4 h (data not shown). Next, we determined the
duration of pre-incubation time needed for curcumin to
achieve maximum inhibition of IL-8 secretion. While 10–
60 min of exposure to 100 μM curcumin resulted in an
approximately 50% reduction of IL-8 secretion (Fig. 5),
200 μM curcumin was associated with complete inhibition.
A period as short 10 min resulted in a significant reduction
of IL-8 secretion (p=0.002, two-tailed t test), but complete
inhibition required an exposure time of 45–60 min.
Duration of inhibition of IL-8 secretion induced by
curcumin Subsequently, we examined the duration of
Fig. 4 Determination of Detroit cell invasion by strain 25238 using a
gentamicin protection assay. Cells were pre-treated with 0, 100, or
200 μM of curcumin for 1 h. Following 3 h of infection, extracellular
bacteria were killed by exposure to gentamicin for 2 h. Following cell
lysis, quantitative bacterial cultures identified viable intracellular
bacteria
Fig. 3 M. catarrhalis adherence assay. Before infection of Detroit,
strain 25238 was pre-incubated with sIgA (100 μg/ml) and/or 50 μM
curcumin for 20 min at 37°C. Pre-treated bacteria and controls were
then used to infect the monolayer, and a standard adherence assay was
performed. Statistical analysis was performed using one-way
ANOVA, *p<0.05. Mean adherence ratios +1 SD of three indepen-
dent experiments, each run in triplicate, are shown
Fig. 2 M. catarrhalis adherence assay. After pre-incubation of Detroit
cells for 60 min with curcumin at the indicated concentrations,
bacteria (a, strain 25238; b, strain O35E) were inoculated at an MOI
of 30 and incubated for 30 min at 37°C. Non-adherent bacteria were
removed, and adherent cells were determined by quantitative culture
of trypsinized cells. Statistics: a overall one-way ANOVA p<0.0001,
*p<0.05 using Bonferroni’s multiple comparisons test. b Overall one-
way ANOVA p=0.0002, *p<0.05. Mean adherence ratios +1 SD of
three independent experiments, each run in triplicate, are shown
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curcumin-induced inhibition of IL-8 secretion by Detroit
cells. This approach required the use of heat-killed bacteria
because Mcat proliferates in MEM. Figure 6 indicates that,
as expected, pre-incubation with 200 μM curcumin not
only resulted in more profound inhibition of IL-8 release
after 4 h but that it also translated in prolonged IL-
8 inhibition (12 h) in comparison with pre-infection
exposure to 100 μM curcumin (4 h). Pre-incubation in this
experiment was carried out for 60 min. Pre-incubation of
strain 25238 with sIgA did not affect IL-8 secretion (data
not shown).
Discussion
Curcumin is a powerful anti-inflammatory agent, which
exerts its main effect by inhibiting activation and nuclear
translocation of NF-κB [34]. Pharmacologically, its major
disadvantage is the extremely poor oral bioavailability. Its
topical use as an anti-inflammatory agent on mucosal
surfaces, obviating the need for systemic absorption, is
thus an attractive approach to its eventual use as a
therapeutic agent [25].
The in vitro data presented here demonstrate that
curcumin is capable of inhibiting the growth of the highly
prevalent facultative pathogen Mcat by exhibiting
concentration-dependent bacteriostatic and bactericidal ac-
tivity (Fig. 1). If applicable to the entire oral flora [23], this
antibacterial effect may contribute to the beneficial effects
of curcumin because the bacterial density on the mucosal
surface affects the severity of cancer chemotherapy- and
radiation-induced mucositis [5] and increases the risk of
systemic infections [11]. Furthermore, curcumin strongly
inhibited epithelial cell adherence and cellular invasion of
Mcat (Figs. 2 and 4, respectively), both being considered
key early events in mucosal infection [22]. Clearly, the use
of one single bacterial species oversimplifies the complex-
ity of the oropharyngeal flora and its interaction with the
mucosa. In addition, the fact that we used prolonged
curcumin exposure times (30–60 min) before infecting the
monolayer with bacteria may not closely mimic the in vivo
use of curcumin mouth washes, which may result in shorter
exposure times. Nevertheless, we consider our Mcat model
useful because this upper respiratory tract organism
commonly switches from commensal to pathogen and vice
versa under appropriate conditions and because its patho-
genicity appears to be density-dependent [24]. In addition,
as discussed below, exposure times as short as 10 min
resulted in significant anti-inflammatory responses. It is
noteworthy that curcumin-inhibited adherence has also
been described for the related organisms Neisseria menin-
gitidis (on A549 lung cells [12]) and Neisseria gonor-
rhoeae (on HeLa cells [35]), respectively. Detroit cells were
used because this epithelial cell line originates from the
human upper respiratory tract, where Mcat typically resides
and where cancer therapy-induced oral lesions frequently
occur. This cell line has previously been investigated for
both its susceptibility to curcumin-induced NF-κB inhibi-
Fig. 5 IL-8 secretion following a 4-h infection with live strain 25238
(MOI 100) as a function of the duration of pre-incubation of Detroit
cells with 100 (square) or 200 μM (triangle) curcumin, respectively.
Uninfected cells pre-incubated with 200 μM curcumin (circle) are
included as negative control. Statistics, *p=0.002 (two-tailed t test
between 0 and 10 min of exposure to 200 μM curcumin)
Fig. 6 IL-8 secretion following a 16-h exposure of Detroit cells with
heat-inactivated strain 25238 at a MOI 0 (uninfected, a) or 100 (b),
respectively. Sixty-minute pre-incubation before exposure with bacte-
ria was carried out with 0 (circle), 100 μM (square), or 200 μM
(triangle) curcumin, respectively
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tion and induction of apoptosis [17]. While activation of NF-
κB was inhibited after 16 h of exposure to up to 100 µM
curcumin, caspase-3 mediated apoptosis was not observed
before 24 h of continuous exposure to curcumin. This
finding is in line with our observation that an exposure time
of 60 min did not induce apoptosis of Detroit cells [17].
Our findings are novel in several respects. First, we
established for the first time dose–response curves for the
antibacterial activity of curcumin for a major upper
respiratory tract and otitis media pathogen (Fig. 1). This is
an important finding because, as mentioned above, the risk
of development of infection, e.g., otitis media caused by
Mcat, Haemophilus influenzae, and Streptococcus pneumo-
niae, correlates with the mucosal surface density of the
organism at the time of florid otitis media [24]. Second,
dose–response curves established that the inhibitory effect
of curcumin on epithelial cell adherence and invasion
clearly is limited to concentrations of curcumin >50 µM
(Figs. 2 and 4, respectively). While other epithelial cell
types may differ in their minimum concentrations needed,
the data maintain that cellular penetration of curcumin
requires a certain minimum extracellular concentration,
when it is to be used as a topical agent on mucosal
surfaces. Third, our time analysis (Fig. 5) indicates that the
duration of contact between curcumin and the epithelial cell
layer has a profound effect on its capacity to inhibit Mcat-
induced pro-inflammatory activation, the occurrence of
which has been firmly established in the literature [10, 28,
33]. Our data indicate that curcumin at a concentration of
100 μM only moderately inhibits IL-8 release and that
maximum inhibition of this key chemokine requires
exposure of Detroit cells to relatively high concentrations
(200 μM) for at least 45 min. Fourth, not surprisingly, the
concentration of curcumin also affected the duration of IL-
8 suppression, in that 200 μM was effective approximately
three times longer (12 h) than 100 μM (4 h; Fig. 6). Of
potential concern was the observation that short-term
suppression by 100 μM resulted in an excessive “rebound”
release of IL-8 after 12 and 16 h, respectively, which may
be an undesirable effect, e.g., in the treatment of cancer
therapy-induced mucositis. We are not aware that such a
rebound phenomenon has previously been described.
On the other hand, we established that co-exposure of
epithelial cells with both salivary IgA and low-dose
curcumin (50 μM) displayed a synergistic or at least
additive effect on the reduction of Mcat-induced inflam-
mation. Since the buccal mucosa is constantly bathed in
IgA-containing saliva, the rebound phenomenon mentioned
above may be mitigated by the presence of saliva in
patients who receive curcumin intermittently and/or at low
doses only.
In conclusion, these data from our in vitro model
demonstrate that curcumin, applied topically to oropharyn-
geal surface epithelia, may have a beneficial effect on local
infection and also on cancer therapy-induced mucositis by
reducing the bacterial load, inhibiting bacterial adherence
and cellular penetration, as well as preventing pro-
inflammatory cytokine release. Additional studies will be
needed because our data also indicate that both the duration
and concentration of curcumin exposure are likely to affect
the potential therapeutic benefit.
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